Recombinant Human Erythropoietin Alfa

Information about Recombinant Human Erythropoietin Alfa

Recombinant human erythropoietin alfa uses

Recombinant Human Erythropoietin Alfa is used in the treatment of anemia, anemia due to chemotherapy and anemia due to chronic kidney disease.

How recombinant human erythropoietin alfa works

Recombinant human erythropoietin alfa is a growth factor that stimulates the bone marrow to produce more red blood cells.

Common side effects of recombinant human erythropoietin alfa

Rash, Injection site pain, Pulmonary thromboembolism, Arterial thromboembolism (blood clot in artery), Edema, Increased blood pressure, Hypersensitivity.

Available Medicine for Recombinant Human Erythropoietin Alfa

  • ₹990
    Septalyst Lifesciences Pvt.Ltd.
    1 variant(s)

Content on this page was last updated on 15 February, 2017, by Dr. Varun Gupta (MD Pharmacology)